A Study of CC-95266 in Participants With Relapsed and/or Refractory Multiple Myeloma
Trial Status: closed to accrual
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-95266 in participants with relapsed and/or refractory multiple myeloma (R/R MM).